BPC 157 Banned: Key Facts on the Latest FDA Decision Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 aka Wolverine. This peptide is not FDA approved, but it is very popular among the biohacking population. Ashley explains the science behind it, but remember, it doesn't have human data yet, so Compounded "semaglutide" is not FDA approved semaglutide.com